Antigen Processing for MHC Class II

Antigen Presenting Cells: From Mechanisms to Drug Development

Volumn , Issue , 2006, Pages 89-128

  Vogt, Anne B ^a   Ploix, Corinne ^a   Kropshofer, Harald ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Antigen presenting cells; Antigen processing; Antigen uptake by APCs; Assembly of MHC II molecules; Export of MHC II; Generation of antigenic peptides; MHC Class II; MHC II organization on cell surface; Molecular mechanisms; Types of antigen presenting cells (APCs); Viral and bacterial interference

Indexed keywords

EID: 84889317204     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527607021.ch4     Document Type: Chapter

References (189)

1. Girvin, A. M., Gordon, K. B., Welsh, C. J., Clipstone, N. A., and Miller, S. D. (2002). Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood 99, 3692-3701.
2. Leiter, E. H., Christianson, G. J., Serreze, D. V., Ting, A. T., and Worthen, S. M. (1989). MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice. J. Exp. Med. 170, 1243-1262.
3. Skoskiewicz, M. J., Colvin, R. B., Schneeberger, E. E., and Russell, P. S. (1985). Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J. Exp. Med. 162, 1645-1664.
4. Steimle, V., Siegrist, C. A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. (1994). Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265, 106-109.
5. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
6. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., and Lanzavecchia, A. (2001). Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393.
7. Schuler, G., Romani, N., and Steinman, R.M. (1985). A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J. Invest. Dermatol. 85, 99s-106s.
8. Tang, A., Amagai, M., Granger, L. G., Stanley, J. R., and Udey, M. C. (1993). Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361, 82-85.
9. Matsuno, K., Ezaki, T., Kudo, S., and Uehara, Y. (1996). A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J. Exp. Med. 183, 1865-1878.
10. Carson, M. J., Reilly, C. R., Sutcliffe, J. G., and Lo, D. (1998). Mature microglia resemble immature antigen-presenting cells. Glia 22, 72-85.
11. Stumbles, P. A., Thomas, J. A., Pimm, C. L., Lee, P. T., Venaille, T. J., Proksch, S., and Holt, P. G. (1998). Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J. Exp. Med. 188, 2019-2031.
12. Nijman, H. W., Kleijmeer, M. J., Ossevoort, M. A., Oorschot, V. M., Vierboom, M. P., van de Keur, M., Kenemans, P., Kast, W. M., Geuze, H. J., and Melief, C. J. (1995). Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182, 163-174.
13. Pierre, P., Turley, S. J., Gatti, E., Hull, M., Meltzer, J., Mirza, A., Inaba, K., Steinman, R. M., and Mellman, I. (1997). Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792.
14. Cella, M., Sallusto, F., and Lanzavecchia, A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16.
15. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J., and Ricciardi-Castagnoli, P. (1997). Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185, 317-328.
16. Stossel, H., Koch, F., Kampgen, E., Stoger, P., Lenz, A., Heufler, C., Romani, N., and Schuler, G. (1990). Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J. Exp. Med. 172, 1471-1482.
17. Zhou, L. J., and Tedder, T. F. (1995). Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154, 3821-3835.
18. Steinman, R. M. and Cohn, Z. A. (1974). Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 139, 380-397.
19. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400.
20. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
21. West, M. A., Wallin, R. P., Matthews, S. P., Svensson, H. G., Zaru, R., Ljunggren, H. G., Prescott, A. R. and Watts, C. (2004). Enhanced dendritic cell antigen capture via toll-like receptorinduced actin remodeling. Science 305, 1153-1157.
22. Underhill, D. M. and Ozinsky, A. (2002). Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20, 825-852.
23. Rubartelli, A., Poggi, A. and Zocchi, M. R. (1997). The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur. J. Immunol. 27, 1893-1900.
24. Blander, J. M. and Medzhitov, R. (2004). Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014-1018.
25. John, B., Herrin, B. R., Raman, C., Wang, Y. N., Bobbitt. K. R., Brody. B. A. and Justement, L. B. (2003). The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction. J. Immunol. 170, 3534-3543.
26. Fanger, N. A., Wardwell, K., Shen, L., Tedder, T. F. and Guyre, P. M. (1996). Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 157, 541-548.
27. Stahl, P. D. and Ezekowitz, R. A. (1998). The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10, 50-55
28. Dong, X., Storkus, W. J. and Salter, R. D. (1999). Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol. 163, 5427-5434.
29. Prigozy, T. I., Sieling, P. A., Clemens, D., Stewart, P. L., Behar, S. M., Porcelli, S. A., Brenner, M. B., Modlin, R. L. and Kronenberg, M. (1997). The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6, 187-197.
30. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M. and Nussenzweig, M. C. (1995). The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-155.
31. Engering, A., Geijtenbeek, T. B., van Vliet, S. J., Wijers, M., van Liempt, E., Demaurex, N., Lanzavecchia, A., Fransen, J., Figdor, C. G., Piguet, V. and van Kooyk Y. (2002). The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168, 2118-2126.
32. Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., Caux, C., Lebecque, S. and Saeland, S. (2000). Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81.
33. Kissenpfennig, A., Ait-Yahia, S., Clair-Moninot, V., Stossel, H., Badell, E., Bordat, Y., Pooley, J. L., Lang, T., Prina, E., Coste, I., Gresser, O., Renno, T., Winter, N., Milon, G., Shortman, K., Romani, N., Lebecque, S., Malissen, B., Saeland, S. and Douillard P. (2005). Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol. Cell Biol. 25, 88-99.
34. Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S. and Underhill, D. M. (2003). Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197, 1107-1117.
35. Schjetne, K. W., Thompson, K. M., Nilsen, N., Flo, T. H., Fleckenstein, B., Iversen, J. G., Espevik, T. and Bogen, B. (2003). Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J. Immunol. 171, 32-36.
36. Geijtenbeek, T. B., van Vliet, S. J., Engering, A,'t Hart, B. A. and van Kooyk, Y. (2004). Self-and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22, 33-54.
37. Kloetzel, P. M. and Ossendorp, F. (2004). Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16, 76-81.
38. Watts, C. (2004). The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5, 685-692.
39. Villadangos, J. A. and Ploegh, H. L. (2000). Proteolysis in MHC class II antigen presentation: who's in charge? Immunity 12, 233-239.
40. Jensen, P. E. (1995). Antigen unfolding and disulfide reduction in antigen presenting cells. Semin. Immunol. 6, 347-353.
41. Arunachalam, B., Phan, U. T., Geuze, H. J. and Cresswell, P. (2000). Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc. Natl. Acad. Sci. U.S.A. 97, 745-750.
42. Maric, M., Arunachalam, B., Phan, U. T., Dong, C., Garrett, W. S., Cannon, K. S., Alfonso, C., Karlsson, L., Flavell, R. A. and Cresswell, P. (2001). Defective antigen processing in GILT-free mice. Science 294, 1361-1365
43. Haque, M. A., Li, P., Jackson, S. K., Zarour, H. M., Hawes, J. W., Phan, U. T., Maric M., Cresswell, P. and Blum, J. S. (2002). Absence of gamma-interferoninducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J. Exp. Med. 195, 1267-1277.
44. Lennon-Dumenil, A. M., Bakker, A. H., Wolf-Bryant, P., Ploegh, H. L. and Lagaudriere-Gesbert, C. (2002). A closer look at proteolysis and MHC-class-IIrestricted antigen presentation. Curr. Opin. Immunol. 14, 15-21.
45. Cresswell, P. (1994). Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
46. Sherman, M. A., Weber, D. A. and Jensen, P. (1995). DMenhances peptide binding to class II MHC by release of invariant chain-derived peptides. Immunity 3, 197-205.
47. Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., Reise Sousa, C., Germain, R. N., Mellman, I. and Steinman, R. M. (2000). The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191, 927-936.
48. Pierre P. and Mellman I. (1998). Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93, 1135-1145.
49. Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. and Mellman, I. (2003). Activation of lysosomal function during dendritic cell maturation. Science 299, 1400-1403.
50. Vogt, A. B. and Kropshofer, H. (1999). HLA-DM-an endosomal/lysosomal chaperone for the immune system. Trends Biochem. Sci. 24, 150-154.
51. Wilson, N. S., El-Sukkari, D. and Villadangos, J. A. (2004). Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187-2195.
52. Rohn, T. A., Boes, M., Wolters, D., Spindeldreher, S., Muller, B., Langen, H., Ploegh, H., Vogt, A. B. and Kropshofer, H. (2004). Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization. Nat. Immunol. 5, 909-918.
53. Veeraswamy, R. K., Cella, M., Colonna, M. and Unanue, E.R. (2003). Dendritic cells process and present antigens across a range of maturation states. J. Immunol. 170, 5367-5372.
54. Cobb, B. A., Wang, Q., Tzianabos, A. O., Kasper, D. L. (2004). Polysaccharide processing and presentation by the MHCII pathway. Cell 117, 677-687.
55. Kornfeld, S. and Mellman, I. (1989). The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5, 483-525.
56. Sercarz, E. E. and Maverakis, E. (2003). MHC-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3, 621-629.
57. Castellino, F., Zappacosta, F., Coligan, J. E. and Germain, R. N. (1998). Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J. Immunol. 161, 4048-4057.
58. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H. L. and Villadangos, J. A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. U.S.A. 95, 4516-4521
59. Driessen, C., Lennon-Dumenil, A. M. and Ploegh H. L. (2001). Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors. Eur. J. Immunol. 31, 1592-1601.
60. Honey, K., Nakagawa, T., Peters, C. and Rudensky, A. (2002). Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. 195, 1349-1358.
61. Hsieh, C. S., deRoos, P., Honey, K., Beers and C., Rudensky, A. Y. (2002). A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168, 2618-2625.
62. Pluger, E. B., Boes, M., Alfonso, C., Schroter, C. J., Kalbacher, H., Ploegh, H.L. and Driessen, C. (2002). Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 32, 467-476.
63. Manoury, B., Hewitt, E. W., Morrice, N., Dando, P. M., Barrett, A.J. and Watts, C. (1998). An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396, 695-699.
64. Manoury, B., Mazzeo, D., Fugger, L., Viner, N., Ponsford, M., Streeter, H., Mazza, G., Wraith, D. C. and Watts, C. (2002). Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3, 169-174.
65. Krogsgaard, M., Wucherpfennig, K. W., Cannella, B., Hansen, B. E., Svejgaard, A., Pyrdol, J., Ditzel, H., Raine, C., Engberg, J. and Fugger, L. (2000). Visualization of myelin basic protein (MBP) Tcell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leuko cyte antigen (HLA)-DR2-MBP 85-99 complex. J. Exp. Med. 191, 1395-1412.
66. Nishioku, T., Hashimoto, K., Yamashita, K., Liou, S. Y., Kagamiishi, Y., Maegawa, H., Katsube, N., Peters, C., von Figura, K., Saftig, P., Katunuma, N., Yamamoto, K. and Nakanishi, H. (2002). Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J. Biol. Chem. 277, 4816-4822.
67. Yee, C.S., Yao, Y., Li, P., Klemsz, M. J., Blum, J. S. and Chang, C. H. (2004). Cathepsin E: a novel target for regulation by class II transactivator. J. Immunol. 172, 5528-5534.
68. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
69. Vogt, A. B., Stern, L. J., Amshoff, C., Dobberstein, B., Hammerling, G. J. and Kropshofer, H. (1995). Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155, 4757-4765.
70. Stumptner, P. and Benaroch, P. (1997). Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16, 5807-5818.
71. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger. J. L. and Wiley, D. C. (1993). Threedimensional structure of the human class II histocompatibility antigen HLADR1. Nature 364, 33-39.
72. Zhong, G., Castellino, F., Romagnoli, P. and Germain, R. N. (1996). Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184, 2061-2066.
73. Doebele, R. C., Pashine, A., Liu, W., Zaller, D. M., Belmares, M., Busch, R. and Mellins, E. (2003). Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism. J. Immunol. 170, 4683-4692.
74. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B. and Sinigaglia, F. (1993). Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74, 197-203.
75. Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F. and Hammer, J. (1999). Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17, 555-561.
76. Herman, A., Kappler, J. W., Marrack, P. and Pullen, A. M. (1991). Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745-772.
77. Li, H., Llera, A., Malchiodi, E. L. and Mariuzza, R. A. (1999). The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 17, 435-466.
78. Hogan, R. J., Van Beek, J., Broussard, D. R., Surman, S. L. and Woodland, D. L. (2001). Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells. J. Immunol. 166, 6514-6522.
79. Melnick, J. and Argon, Y. (1995). Molecular chaperones and the biosynthesis of antigen receptors. Immunol. Today 16, 243-250.
80. Cresswell, P. (1996). Invariant chain structure and MHC class II function. Cell 84, 505-507
81. Busch, R., Cloutier, I., Säkaly, R.-P. and Hómmerling, G. J. (1996). Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15, 418-428.
82. Blum, J. S. and Cresswell, P. (1988). Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. U.S.A. 85, 3975-3979.
83. Manoury, B., Mazzeo, D., Li, D. N., Billson, J., Loak, K., Benaroch. P. and Watts, C. (2003). Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity 18, 489-498
84. Riese, R. J., Wolf, P. R., Bromme, D., Natkin, L. R., Villadangos, J. A., Ploegh, H.L and Chapman, H. A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357-366.
85. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J. A., Ploegh, H., Peters, C. and Rudensky, A. Y. (1998). Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280, 450-453.
86. Nakagawa, T. Y., Rudensky, A. Y. (1999). The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172, 121-129.
87. Shi, G. P., Bryant, R. A., Riese, R., Verhelst, S., Driessen, C., Li, Z., Bromme, D., Ploegh, H. L. and Chapman, H. A. (2000). Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191, 1177-1186.
88. Biroc, S. L., Gay, S., Hummel, K., Magill, C., Palmer, J. T., Spencer, D. R., Sa, S., Klaus, J. L., Michel, B. A., Rasnick, D. and Gay, R. E. (2001). Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor. Arthritis Rheum. 44, 703-711.
89. Podolin, P. L., Gapper, E. A., Bolognese, B. J., Ghalupowicz, D. G., Dong, X., Fox,.J. H., Gao, E. N., Johanson R. A., Katchur, S. and Marshall, L. A. (2001). Inhibition of cathepsin S blocks invariant chain processing and antigeninduced proliferation in vitro and reduces the severity of collagen-induced arthritis in vivo. Inflamm. Res. 50, S159.
90. Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P., Palmer, J. T., Karp, E. R., De Sanctis, G. T., Ploegh, H. L. and Chapman, H. A. (1998). Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101, 2351-2363.
91. Thurmond, R. L., Sun, S., Sehon, C. A., Baker, S. M., Cai, H., Gu, Y., Jiang, W., Riley, J. P., Williams, K. N., Edwards, J. P. and Karlsson, L. (2004). Identification of a potent and selective noncovalent cathepsin S inhibitor. J. Pharmacol. Exp. Ther. 308, 268-276.
92. Kropshofer, H., Vogt, A. B., Stern, L. J. and Hómmerling, G. J. (1995). Selfrelease of CLIP in peptide loading of HLA-DR molecules. Science 270, 1357-1359.
93. Kelly, A. P., Monaco, J. J., Cho, S. and Trowsdale, J. (1991). A new human HLA class II-related locus. Nature 353, 571-573.
94. Cho, S., Attaya, M. and Monaco, J. J. (1991). New class II-like genes in the murine MHC. Nature 353, 573-576.
95. Mosyak, L., Zaller, D. M. and Wiley, D.C. (1998). The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9, 377-383.
96. Arndt, S.O., Vogt, A. B., Markovic-Plese, S., Martin, R., Moldenhauer, G., Wülpl, A., Sun, Y., Schadendorf, D., Hómmerling, G. J. and Kropshofer, H. (2000). Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 19, 1241-1251.
97. Sanderson, F., Kleijmeer, M., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J., Geuze, H. J. and Trowsdale, J. (1994). Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-1569.
98. Sloan V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E. and Zaller, D. M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
99. Alfonso, C. and Karlsson, L. (2000). Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18, 113-142.
100. Vogt, A. B., Kropshofer, H., Moldenhauer, G. and Hómmerling, G. J. (1996). Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl. Acad. Sci. U.S.A. 93, 9724-9729.
101. Kropshofer, H., Arndt, S. O., Moldenhauer, G., Hómmerling, G. J. and Vogt, A. B. (1997). HLA-DM acts as a molecular chaperone and rescues empty HLADR molecules at lysosomal pH. Immunity 6, 293-302.
102. Schafer, P. H., Green, J. M., Malapati, S., Gu, L. and Pierce, S. K. (1996). HLADM is present in one-fifth the amount of HLA.DR in the class II peptide loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. J. Immunol. 157, 5487-5495.
103. Denzin, L. K., Hammond, C. and Cresswell, P. (1996). HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184, 2153-2165.
104. Weber, D. A., Dao, C. T., Jun, J., Wigal, J. L. and Jensen, P. E. (2001). Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J. Immunol. 167, 5167-5174.
105. Kropshofer, H., Spindeldreher, S., Rohn, T. A., Platania, N., Grygar, C., Daniel, N., Wolpl, A., Langen, H., Horejsi, V. and Vogt, A. B. (2002). Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3, 61-68.
106. Doebele, R. C., Busch, R., Scott, H. M., Pashine, A. and Mellins, E. D. (2000). Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13, 517-527.
107. Pashine, A., Busch, R., Belmares, M. P., Munning, J. N., Doebele, R. C., Buckingham, M., Nolan, G. P. and Mellins, E. D. (2003). Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 19, 183-192.
108. Marin-Esteban, V., Falk, K. and Rotzschke, O. (2004). "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J. Biol. Chem. 279, 50 684-50 690.
109. Verreck, F. A., Fargeas, C. A. and Hammerling, G. J. (2001). Conformational alterations during biosynthesis of HLADR3 molecules controlled by invariant chain and HLA-DM. Eur. J. Immunol. 31, 1029-1036.
110. Schmitt, L., Boniface, J. J., Davis, M. M. and McConnell, H. M. (1998). Kinetic isomers of a class II MHC-peptide complex. Biochemistry 37, 17 371-17 380.
111. Rabinowitz, J. D., Tate, K., Lee, C., Beeson, C. and McConnell, H. M. (1997). Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex. Proc. Natl. Acad. Sci. U.S.A. 94, 8702-8707.
112. He, X. L., Radu, C., Sidney, J., Sette, A., Ward, E. S. and Garcia, K. C. (2002). Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity 17, 83-94.
113. Viret, C., He, X. and Janeway, C. A. Jr. (2003). Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection. Proc. Natl. Acad. Sci. U.S.A. 100, 5354-5359.
114. Pu, Z., Lovitch, S. B., Bikoff, E. K. and Unanue, E. R (2004). T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 20, 467-476.
115. Kropshofer, H., Hammerling, G. J. and Vogt, A. B. (1997). How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 18, 77-82.
116. Kropshofer, H., Vogt, A. B., Moldenhauer, G., Hammer, J., Blum, J. S. and Hammerling, G. J. (1996). Editing of the HLA-DR-peptide repertoire by HLADM. EMBO J. 15, 6144-6154
117. van Ham, S. M., Grúneberg, U., Malcharek, G., Brüker, I., Melms, A. and Trowsdale, J. (1996). Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184, 2019-2024.
118. Weber, D. A., Evavold, B. D. and Jensen, P. E. (1996). Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274, 618-620.
119. Raddrizzani, L., Bono, E., Vogt, A. B., Kropshofer, H., Gallazzi, F., Sturniolo, T., Hómmerling, G. J., Sinigaglia, F. and Hammer, J. (1999). Identification of destabilizing residues in HLA class IIselected bacteriophage display libraries edited by HLA-DM. Eur. J. Immunol. 29, 660-668.
120. Stratikos, E., Wiley, D. C. and Stern, L. J. (2004). Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain. J. Immunol. 172, 1109-1117.
121. Lovitch, S. B., Petzold, S. J. and Unanue, E. R. (2003). Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing. J. Immunol. 171, 2183-2186.
122. Hall, F. C., Rabinowitz, J. D., Busch, R., Visconti, K. C., Belmares, M., Patil, N. S., Cope, A. P., Patel, S., McConnell, H. M., Mellins, E. D. and Sonderstrup, G. (2002). Relationship between kinetic stability and immunogenicity of HLADR4/peptide complexes. Eur. J. Immunol. 32, 662-670.
123. Lich, J. D., Jayne, J. A., Zhou, D., Elliott, J. F. and Blum, J. S. (2003). Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. J. Immunol. 171, 853-859.
124. Kropshofer, H., Hómmerling, G. J. and Vogt, A.B. (1999).The impact of the nonclassical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172, 267-278.
125. Liljedahl, M., Kuwana, T., Fung-Leung, W.-P., Jackson, M. R., Peterson, P. A. and Karlsson, L. (1996). HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15, 4817-4824
126. van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H., Reits, E., Pastoors, L. and Neefjes, J. (2001). Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 167, 884-892.
127. Chen, X., Laur, O., Kambayashi, T., Li, S., Bray, R. A., Weber, D. A., Karlsson, L. and Jensen, P. E. (2002). Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 195, 1053-1062.
128. Kropshofer, H., Vogt, A. B., Thery, C., Armandola, E. A., Li, B.-C., Moldenhauer, G., Amigorena, S. and Hómmerling, G. J. (1998). A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 17, 2971-2981.
129. Hammond, C., Denzin, L. K., Pan, M., Griffith, J. M., Geuze, H. J. and Cresswell, P. (1998). The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR,-DM, and-DO molecules. J. Immunol. 161, 3282-3291
130. van Ham, M., van Lith, M., Lillemeier, B., Tjin, E., Gruneberg, U., Rahman, D., Pastoors, L., van Meijgaarden, K., Roucard, C., Trowsdale, J., Ottenhoff, T., Pappin, D. and Neefjes, J. (2000). Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 191, 1127-1136
131. van Ham, S. M., Tijn, E. P. M., Lillemeier, B. F., Grúneberg, U., van Meijgaarden, K. E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., Ottenhoff, T. H. M., Pappin, D. J. C., Trowsdale, J. and Neefjes, J. (1997). HLA-DO is a negative modulator of HLA-DM mediated MHC class II peptide loading. Curr. Biol. 7, 950-957.
132. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J. and Cresswell, P. (1997). Negative regulation by HLADO of MHC class II-restricted antigen processing. Science 278, 106-109.
133. Perraudeau, M., Taylor, P. R., Stauss, H. J., Lindstedt, R., Bygrave, A. E., Pappin, D. J., Ellmerich, S., Whitten, A., Rahman, D., Canas, B., Walport, M. J., Botto, M. and Altmann, D. M. (2000). Altered major histocompatibility complex class II peptide loading in H2-Odeficient mice. Eur. J. Immunol. 30, 2871-2880.
134. Brocke, P., Armandola, E., Garbi, N. and Hammerling, G. J. (2003). Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes. Eur. J. Immunol. 33, 411-421.
135. Alfonso, C., Williams, G. S., Han, J. O., Westberg, J. A., Winqvist, O. and Karlsson, L. (2003). Analysis of H2-O influence on antigen presentation by B cells. J. Immunol. 171, 2331-2337.
136. Fallas, J. L., Tobin, H. M., Lou, O., Guo, D., Sant'Angelo, D. B. and Denzin, L. K. (2004). Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J. Immunol. 173, 1549-1560.
137. Glazier, K. S., Hake, S. B., Tobin, H. M., Chadburn, A., Schattner, E. J. and Denzin, L. K. (2002). Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J. Exp. Med. 195, 1063-1069.
138. Boes, M., Cuvillier, A. and Ploegh, H. (2004). Membrane specializations and endosome maturation in dendritic cells and B cells. Trends Cell Biol. 14, 175-183.
139. Vogt, A. B., Spindeldreher, S. and Kropshofer, H. (2002). Clustering of MHCpeptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains. Immunol. Rev. 189, 136-151.
140. Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L. and Geuze, H. J. (1991). Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349, 669-676.
141. Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O. and Geuze, H. J. (1998). Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273, 20 121-20 127.
142. Szollosi, J., Horejsi, V., Bene, L., Angelisova, P. and Damjanovich, S. (1996). Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157, 2939-2946.
143. Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C., Billard, M., Conjeaud, H. and Boucheix, C. (1996). CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26, 2657-2665.
144. Tarrant, J. M., Robb, L., van Spriel, A. B. and Wright, M. D. (2003). Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol. 24, 610-617.
145. Kitadokoro, K., Bordo, D., Galli, G., Petracca, R., Falugi, F., Abrignani, S., Grandi, G. and Bolognesi, M. (2001). CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J. 20, 12-18.
146. Bromley, S. K., Iaboni, A., Davis, S. J., Whitty, A., Green, J. M., Shaw, A. S., Weiss, A. and Dustin, M. L. (2001). The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2, 1159-1166.
147. Mittelbrunn, M., Yanez-Mo, M., Sancho, D., Ursa, A. and Sanchez-Madrid, F. (2002). Dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J. Immunol. 169, 6691-6695.
148. Topilski, I., Harmelin, A., Flavell, R. A., Levo, Y. and Shachar, I. (2002). Preferential Th1 immune response in invariant chain-deficient mice. J. Immunol. 168, 1610-1617.
149. Chaturvedi, P., Hengeveld, R., Zechel, M. A., Lee-Chan, E. and Singh, B. (2000). The functional role of class IIassociated invariant chain peptide (CLIP) in its ability to variably modulate immune responses. Int. Immunol. 12, 757-765.
150. Drbal, K., Angelisova, P., Rasmussen, A. M., Hilgert, I., Funderud, S. and Horejsi, V. (1999). The nature of the subset of MHC class II molecules carrying the CDw78 epitopes. Int. Immunol. 11, 491-498.
151. Irvine, D. J., Purbhoo, M. A., Krogsgaard, M. and Davis, M. M. (2002). Direct observation of ligand recognition by T cells. Nature 419, 845-849.
152. Li, Q. J., Dinner, A. R., Qi, S., Irvine, D. J., Huppa, J. B., Davis M. M. and Chakraborty, A. K. (2004). CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat. Immunol. 5, 791-799.
153. Wu, L. C., Tuot, D. S., Lyons, D. S., Garcia, K. C. and Davis, M.M. (2002). Twostep binding mechanism for T-cell receptor recognition of peptide MHC. Nature 418, 552-556.
154. Constant, S. L. and Bottomly, K. (1997). Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15, 297-322.
155. Anderson, H. A., Hiltbold, E. M. and Roche, P. A. (2000). Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1, 156-162.
156. Hiltbold, E. M., Poloso, N. J. and Roche, P. A. (2003). MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J. Immunol. 170, 1329-1338.
157. Edidin, M. (2003). The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32, 257-283.
158. Karacsonyi, C., Knorr, R., Fulbier, A. and Lindner, R. (2004). Association of major histocompatibility complex II with cholesterol-and sphingolipid-rich membranes precedes peptide loading. J. Biol. Chem. 279, 34 818-34 826.
159. Hart, D. N. (1997). Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90, 3245-3287.
160. Kleijmeer, M. J., Morkowski, S., Griffith, J. M., Rudensky, A. Y. and Geuze, H. J. (1997). Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139, 639-649.
161. Kleijmeer, M., Ramm, G., Schuurhuis, D., Griffith, J., Rescigno, M., Ricciardi-Castagnoli, P., Rudensky, A. Y., Ossendorp, F., Melief, C. J., Stoorvogel, W. and Geuze, H. J. (2001). Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 155, 53-63
162. van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H., Reits, E., Pastoors, L. and Neefjes, J. (2001). Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 167, 884-892.
163. Murk, J. L., Humbel, B. M., Ziese, U., Griffith, J. M., Posthuma, G., Slot, J. W., Koster, A. J., Verkleij, A. J., Geuze, H. J. and Kleijmeer, M. J. (2003). Endosomal compartmentalization in three dimensions: implications for membrane fusion. Proc. Natl. Acad. Sci. U.S.A. 100, 13 332-13 337.
164. Amigorena, S., Drake, J. R., Webster, P. and Mellman, I. (1994). Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369, 113-120.
165. Turley, S. J., Inaba, K., Garrett, W. S., Ebersold, M., Unternaehrer, J., Steinman, R. M. and Mellman, I. (2000). Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288, 522-527.
166. Chow, A., Toomre, D., Garrett, W. and Mellman, I. (2002). Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994.
167. Boes, M. and Ploegh, H. L. (2004). Translating cell biology in vitro to immunity in vivo. Nature 430, 264-271.
168. Boes, M., Bertho, N., Cerny, J., Op den Brouw, M., Kirchhausen, T. and Ploegh, H. (2003). T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner. J. Immunol. 171, 4081-4088.
169. Montoya, M. C., Sancho, D., Bonello, G., Collette, Y., Langlet, C., He, H. T., Aparicio, P., Alcover, A., Olive, D. and Sanchez-Madrid, F. (2002). Role of ICAM-3 in the initial interaction of T lymphocytes and APCs. Nat. Immunol. 3, 159-168.
170. Bertho, N., Cerny, J., Kim, Y. M., Fiebiger, E., Ploegh, H. and Boes, M. (2003). Requirements for T cell-polarized tubulation of class II+ compartments in dendritic cells. J. Immunol. 171, 5689-5696.
171. Hmama, Z., Gabathuler, R., Jefferies, W. A., de Jong, G. and Reiner, N. E. (1998). Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161, 4882-4893.
172. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A. and Bloom, B. R. (1993). An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254.
173. Pai, R. K., Convery, M., Hamilton, T. A., Boom, W. H. and Harding, C. V. (2003). Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171, 175-184.
174. Chu, R. S., Askew, D., Noss, E. H., Tobian, A., Krieg, A. M. and Harding, C. V. (1999). CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J. Immunol. 163, 1188-1194.
175. Noss, E. H., Pai, R. K., Sellati, T. J., Radolf, J. D., Belisle, J., Golenbock, D. T., Boom, W. H. and Harding, C. V. (2001). Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167, 910-918.
176. Gehring, A. J., Dobos, K. M., Belisle, J. T., Harding, C. V. and Boom, W. H. (2004). Mycobacterium tuberculosis LprG (Rv1411c). A novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173, 2660-2668.
177. Fortune, S. M., Solache, A., Jaeger, A., Hill, P. J., Belisle, J. T., Bloom, B. R., Rubin, E. J. and Ernst, J. D. (2004). Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and-independent mechanisms. J. Immunol. 172, 6272-6280.
178. Geijtenbeek, T. B., Van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M., Appelmelk, B. and Van Kooyk, Y. (2003). Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197, 7-17.
179. Zhong, G., Fan, T. and Liu, L. (1999). Chlamydia inhibits interferon gammainducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189, 1931-1938.
180. De Souza Leao, S., Lang, T., Prina, E., Hellio, R. and Antoine, J. C. (1995). Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 108, 3219-3231.
181. Moutaftsi, M., Mehl, A. M., Borysiewicz, L. K.and Tabi, Z. (2002). Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99, 2913-2921.
182. Grigoleit, U., Riegler, S., Einsele, H., Laib Sampaio, K., Jahn, G., Hebart, H., Brossart, P., Frank, F. and Sinzger, C. (2002). Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells. Br. J. Haematol. 119, 189-198.
183. Johnson, D. C. and Hegde, N. R. (2002). Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Curr. Top. Microbiol. Immunol. 269, 101-115.
184. Tomazin, R., Boname, J., Hegde, N. R., Lewinsohn, D. M., Altschuler, Y., Jones, T. R., Cresswell, P., Nelson, J. A., Riddell, S. R. and Johnson, D. C. (1999). Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 5, 1039-1043.
185. Pollara, G., Speidel, K., Samady, L., Rajpopat, M., McGrath, Y., Ledermann, J., Coffin, R. S., Katz, D. R. and Chain, B. (2003). Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J. Infect. Dis. 187, 165-178.
186. Neumann, J., Eis-Hubinger, A. M. and Koch, N. (2003). Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 171, 3075-3083.
187. Stumptner-Cuvelette, P., Morchoisne, S., Dugast, M., Le Gall, S., Raposo, G., Schwartz, O. and Benaroch, P. (2001). HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U.S.A. 98, 12 144-12 149.
188. Ressing, M. E., van Leeuwen, D., Verreck, F. A., Gomez, R., Heemskerk, B., Toebes, M., Mullen, M. M., Jardetzky, T. S., Longnecker, R., Schilham, M. W., Ottenhoff, T. H., Neefjes, J., Schumacher, T. N., Hutt-Fletcher, L. M. and Wiertz, E. J. (2003). Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl. Acad. Sci. U.S.A. 100, 11 583-11 588.
189. Molinari, M., Salio, M., Galli, C., Norais, N., Rappuoli, R., Lanzavecchia, A. and Montecucco, C. (1998). Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187, 135-140.